| IL-1 receptor antagonist ameliorates inflammasome-dependent inflammation in murine and human cystic fibrosis RG Iannitti, V Napolioni, V Oikonomou, A De Luca, C Galosi, M Pariano, ... Nature communications 7 (1), 10791, 2016 | 235 | 2016 |
| Nonalcoholic fatty pancreas disease and Nonalcoholic fatty liver disease: more than ectopic fat C Della Corte, A Mosca, F Majo, V Lucidi, N Panera, E Giglioni, L Monti, ... Clinical endocrinology 83 (5), 656-662, 2015 | 145 | 2015 |
| A mast cell-ILC2-Th9 pathway promotes lung inflammation in cystic fibrosis S Moretti, G Renga, V Oikonomou, C Galosi, M Pariano, RG Iannitti, ... Nature communications 8 (1), 14017, 2017 | 128 | 2017 |
| Gut microbiota signatures in cystic fibrosis: Loss of host CFTR function drives the microbiota enterophenotype P Vernocchi, F Del Chierico, A Russo, F Majo, M Rossitto, M Valerio, ... PloS one 13 (12), e0208171, 2018 | 102 | 2018 |
| Nuclear magnetic resonance–based metabolomics discriminates primary ciliary dyskinesia from cystic fibrosis P Montuschi, D Paris, S Montella, D Melck, V Mirra, G Santini, N Mores, ... American journal of respiratory and critical care medicine 190 (2), 229-233, 2014 | 47 | 2014 |
| Hypoxia promotes danger-mediated inflammation via receptor for advanced glycation end products in cystic fibrosis RG Iannitti, A Casagrande, A De Luca, C Cunha, G Sorci, F Riuzzi, ... American Journal of Respiratory and Critical Care Medicine 188 (11), 1338-1350, 2013 | 46 | 2013 |
| Lack of efficacy of Lactobacillus GG in reducing pulmonary exacerbations and hospital admissions in children with cystic fibrosis: A randomised placebo controlled trial E Bruzzese, V Raia, E Ruberto, R Scotto, A Giannattasio, D Bruzzese, ... Journal of cystic fibrosis 17 (3), 375-382, 2018 | 37 | 2018 |
| Fatty liver and insulin resistance in children with hypobetalipoproteinemia: the importance of aetiology C Della Corte, D Fintini, U Giordano, M Cappa, C Brufani, F Majo, ... Clinical endocrinology 79 (1), 49-54, 2013 | 37 | 2013 |
| Liposomes loaded with bioactive lipids enhance antibacterial innate immunity irrespective of drug resistance N Poerio, F Bugli, F Taus, MB Santucci, C Rodolfo, F Cecconi, R Torelli, ... Scientific reports 7 (1), 45120, 2017 | 36 | 2017 |
| Overweight and obesity in adults with cystic fibrosis: an Italian multicenter cohort study A Gramegna, S Aliberti, M Contarini, D Savi, G Sotgiu, F Majo, L Saderi, ... Journal of Cystic Fibrosis 21 (1), 111-114, 2022 | 29 | 2022 |
| Glucose tolerance affects pubertal growth and final height of children with cystic fibrosis C Bizzarri, E Montemitro, S Pedicelli, S Ciccone, F Majo, M Cappa, ... Pediatric pulmonology 50 (2), 144-149, 2015 | 29 | 2015 |
| Italian Cystic Fibrosis Registry (ICFR). Report 2015-2016 B Giordani, A Amato, F Majo, G Ferrari, S Quattrucci, L Minicucci, ... Epidemiologia e Prevenzione 43 (4S1), 1-36, 2019 | 26* | 2019 |
| Ivacaftor improves lung disease in patients with advanced CF carrying CFTR mutations that confer residual function D Salvatore, V Terlizzi, M Francalanci, G Taccetti, B Messore, C Biglia, ... Respiratory Medicine 171, 106073, 2020 | 25 | 2020 |
| Pancreatic disorders in children: New clues on the horizon C Della Corte, S Faraci, F Majo, V Lucidi, DS Fishman, V Nobili Digestive and Liver Disease 50 (9), 886-893, 2018 | 25 | 2018 |
| Rates of depression and anxiety in Italian patients with cystic fibrosis and parent caregivers: implementation of the mental health guidelines S Graziano, B Spanò, F Majo, D Righelli, L Vincenzina, A Quittner, ... Respiratory medicine 172, 106147, 2020 | 23 | 2020 |
| State-of-the-art review of lung imaging in cystic fibrosis with recommendations for pulmonologists and radiologists from the “iMAging managEment of cySTic fibROsis”(MAESTRO … P Ciet, S Bertolo, M Ros, R Casciaro, M Cipolli, S Colagrande, S Costa, ... European Respiratory Review 31 (163), 2022 | 22 | 2022 |
| Remote telematic control in cystic fibrosis F Murgia, M Cilli, E Renzetti, F Majo, D Soldi, V Lucidi, F Bella, S Bella Clin Ter 162 (4), e121-4, 2011 | 20 | 2011 |
| Genetic polymorphisms affecting IDO1 or IDO2 activity differently associate with aspergillosis in humans V Napolioni, M Pariano, M Borghi, V Oikonomou, C Galosi, A De Luca, ... Frontiers in immunology 10, 890, 2019 | 18 | 2019 |
| Patients with cystic fibrosis having a residual function mutation: Data from the Italian registry D Salvatore, R Padoan, R Buzzetti, A Amato, B Giordani, G Ferrari, F Majo Pediatric Pulmonology 54 (2), 150-157, 2019 | 18 | 2019 |
| Clinical outcomes of a large cohort of individuals with the F508del/5T; TG12 CFTR genotype A Tosco, A Castaldo, C Colombo, L Claut, V Carnovale, P Iacotucci, ... Journal of Cystic Fibrosis 21 (5), 850-855, 2022 | 17 | 2022 |
